CRYOPDP acquires Bluebird Express

Bluebird Express: A Legacy of Logistics Expertise

Founded in 2002 by James Gillett and Raymond Boccia, Bluebird Express has accumulated over 20 years of experience in logistics solutions. The company specializes in both domestic and international air and ground transportation, making it a seasoned player in the industry. With key operational centres in Los Angeles (LAX) and New York (JFK), Bluebird Express boasts credentials that include being a fully accredited cargo agent certified by the International Air Transport Association (IATA) and an indirect air carrier (IAC) authorised and regulated by the Transportation Security Administration (TSA).

CRYOPDP’s Growing Market

CRYOPDP’s reputation in the cell and gene therapy industry has been growing in the last few years. The company’s mission revolves around improving global health by providing innovative temperature-controlled logistics solutions to the Clinical Research and Cell & Gene therapy communities. This mission adds significance as the United States leads the way in cell and gene therapy clinical trials, with over 400 companies actively developing products for various applications.

The Synergy of Collaboration

According to our CEO, Cedric Picaud, the inclusion of Bluebird Express and its experienced team aligns perfectly with CRYOPDP’s strategic focus on the life sciences industry, especially within cell and gene therapy. This strategic collaboration significantly strengthens CRYOPDP’s presence in the United States, enhancing our capabilities and delivering added value to our esteemed clients.

The expansion into New York and Los Angeles will not only increase the company’s U.S. footprint but also further enhance its global infrastructure and competencies. The synergy between the two entities creates opportunities for global cross-selling and growth within the organization.

CRYOPDP: A Global Reach

CRYOPDP’s impact extends far beyond U.S. borders. With operations spanning 16 countries worldwide and a clientele in over 135 countries, we acknowledge the crucial role that temperature-controlled logistics plays in the life sciences industry. We provide premium transport solutions and tailor-made services, earning a reputation for reliability, flexibility, and extensive global logistics expertise.

About Cryoport, Inc.

Cryoport, Inc. (Nasdaq: CYRX) is a global provider of innovative products and services to the fast-growing cell and gene therapy industry. With strategic locations across the Americas, EMEA (Europe, the Middle East, and Africa), and APAC (Asia Pacific), Cryoport’s global platform offers essential bio-logistics, bio-storage, bio-processing, and cryogenic systems to the worldwide life sciences markets.

For more in-depth information, we invite you to read the full press release to discover the latest developments and insights into this exciting collaboration.